This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Austin, P R Articles by Hovde, C J Search for Related Content PubMed PubMed Citation Articles by Austin, P R Articles by Hovde, C J

research-article

Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity.

Department of Microbiology, Molecular Biology, and Biochemistry, University of Idaho, Moscow 83843.

ABSTRACT

Escherichia coli Shiga-like toxin type I (SLT-I) is a potent cytotoxin consisting of an enzymatically active A subunit and a pentameric B subunit that mediates toxin binding to susceptible eukaryotic cells. Evidence that the carboxy-terminal 38 amino acids of the A subunit are involved in holotoxin 1A:5B association is presented. We compared the ability of purified recombinant SLT-I B subunit (Slt-IB) to combine in vitro with purified recombinant SLT-I A subunit (Slt-IA; full-length subunit A includes amino acids 1 to 293) and its ability to combine with purified recombinant SLT-I A1 subunit (Slt-IA1; truncated subunit A includes amino acids 1 to 255). Each mixture was analyzed for biological and physical evidence of toxin assembly. Although Slt-IA successfully combined with Slt-IB to form a molecular species similar to holotoxin that was detectable by nondenaturing polyacrylamide gel electrophoresis and immunoblotting and yielded a molecule which was cytotoxic to cultured Vero cells, Slt-IA1 did not have this ability. Slt-IA1 was 36-fold more active than Slt-IA in an in vitro protein synthesis inhibition assay. These findings suggest that the Slt-IA2 fragment is crucial for formation of SLT holotoxin and stabilizes the interaction between the A and B subunits.

This article has been cited by other articles:

• Basu, I., Ferens, W. A., Stone, D. M., Hovde, C. J. (2003). Antiviral Activity of Shiga Toxin Requires Enzymatic Activity and Is Associated with Increased Permeability of the Target Cells. Infect. Immun. 71: 327-334 [Abstract] [Full Text]  
• Leung, P. H. M., Peiris, J. S. M., Ng, W. W. S., Yam, W. C. (2002). Polyclonal Antibodies to Glutathione S-Transferase- Verotoxin Subunit A Fusion Proteins Neutralize Verotoxins. CVI 9: 687-692 [Abstract] [Full Text]  
• Suhan, M. L., Hovde, C. J. (1998). Disruption of an Internal Membrane-Spanning Region in Shiga Toxin 1 Reduces Cytotoxicity. Infect. Immun. 66: 5252-5259 [Abstract] [Full Text]